Clinical Trial Update: Randomized Study Using SM-030 Gel for Adults With Melasma [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating SM-030 Gel for adults with melasma is currently recruiting, sponsored by DermBiont, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Drugs mentioned

• SM-030 Gel

Snippet

Sponsor: DermBiont, Inc. | Conditions: Melasma | Phase 2 | Status: RECRUITING